Novatide Inquiry0 items

Fat Metabolism & Lipotropics

AOD9604 AOD

hGH fragment analogue

Modified C-terminal fragment of human growth hormone with an added tyrosine, studied in mice for effects on fat oxidation.

Human data

Evidence level. Published human clinical data exists, from trials or approved use. About the badges

AOD96042 mgLyophilised PowderFOR RESEARCH USE ONLY
Class
hGH fragment analogue
Type
Single compound
Abbreviation
AOD
Development and regulatory status
Not approved as a drug; obesity development stopped in 2007

What researchers study

AOD9604 is a modified fragment from the C-terminal region of human growth hormone, with an added tyrosine. In mice it raised fat oxidation without the hyperglycaemia or cell-proliferation effects seen with intact hormone.

Research areas

  • Lipolysis and fat oxidation in adipocytes and rodents
  • Beta-3 adrenergic receptor role in lipolysis
  • Comparison with intact growth hormone effects
  • Structure-activity studies of hormone fragments

Reported findings

Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.

  1. rodent

    In obese mice, chronic exposure reduced body weight gain similarly to hGH, raised fat oxidation and plasma glycerol, and did not cause hyperglycaemia

  2. rodent

    A closely related fragment (AOD9401) reduced weight gain and adipocyte diameter in obese Zucker rats without causing insulin resistance

  3. phase 2 trial

    A 24-week phase 2b trial in 536 adults found no tested dose significantly different from placebo at its primary endpoint

Studied alongside

Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.

Related profiles

Related compounds

All Fat Metabolism & Lipotropics

Need several compounds quoted together

Collect every compound and size in one inquiry list. You can also describe a requirement in the message field if it is not in the catalogue.